• Home
  • Meetings
  • Online Activities
  • Patient Educcation
  • Resources
  • Industry Information
Skip Navigation Links.
Activity Information
Introduction
Summary
Expert Perspective
Q & A
Finish

Online CME Activity

The Effect of NSAIDs on Acute Urinary Retention

NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Title:
The Effect of NSAIDs on Acute Urinary Retention
Expiration Date:
10/31/2006
Topics:
Obesity, Benign Prostatic Hypertrophy, Men's Health
Primary Audience:
Primary Care
Activity Format:
Expert Perspective
Credits:
1.00 AMA PRA Category 1 Credits™

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Full Star 99%
UPN:
947

Learning Objective

Participants should be able to highlight at least two key findings of the study presented in this activity and discuss the applicability of these findings to clinical practice.

Accreditation

This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
1.00 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for Pri-Med Institute designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
View Additional Accreditation Information

Faculty and Editorial Board

Written By: Allen D. Seftel, MD, Professor of Urology, Case Western Reserve University, Cleveland, OH; Department of Urology, University Hospitals of Cleveland, Cleveland, OH

Financial Disclosure Statement(s)

Dr. Seftel is a consultant for Sanofi~Synthelabo.

Education Partner:

Commercial Support:

Merck & Co., Inc.

Pri-Med Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.